Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


14 Items
Title  Creator  Group name  Publishing year 
Prognostic Value of 18F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE Combet-Curt et al. EquipeJPP 2024-08-01
GRECCAR 14 - a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol Rouanet et al. EquipeMY 2023-10
[Non-pharmalogical interventions and breast cancer: What benefit in addition to radiotherapy?] Lognos et al. EquipeJPP 2022-06
Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management Quesada et al. EquipeJPP 2022
Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy Prunaretty et al. EquipeJPP 2022
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ Bourgier et al. EquipeJPP 2021-11
Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure de Meric de Bellefon et al. EquipeJPP 2020-03
Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective study Lemanski et al. EquipeCTCS 2020-04
Management of the Axilla in the Era of Breast Cancer Heterogeneity de Meric de Bellefon et al. EquipeAP 2018
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial Bourgier et al. EquipeNB Mar 20, 2018
Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy Lauche et al. EquipeNB Aug 28, 2016
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial Azria et al. EquipeNB Dec 2015
Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients Riou et al. EquipeNB Oct 14, 2015
[Partial breast irradiation] Bourgier et al. EquipeNB Jan 01, 2014
14 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés